Harmony Biosciences Holdings (HRMY) Preferred Stock Liabilities (2019 - 2020)

Harmony Biosciences Holdings has disclosed Preferred Stock Liabilities across 2 years of filings, most recently posting $434.0 million for Q2 2020.

• Preferred Stock Liabilities for Q2 2020 came in at $434.0 million, changed N/A year-over-year; the trailing twelve-month figure through Jun 2020 was $434.0 million (changed N/A YoY), and the FY2019 annual result was $411.3 million, changed N/A from the prior year.
• Preferred Stock Liabilities came in at $434.0 million for Q2 2020 at Harmony Biosciences Holdings, up from $411.3 million in the prior quarter.
• In the past five years, Preferred Stock Liabilities ranged from a high of $434.0 million in Q2 2020 to a low of $400.9 million in Q3 2019.